Inhaled insulin was licensed for use in 2006 but has been withdrawn from the market because of low patronage.Oman Medical Journal is an Open Access International Journal, which intends to engage and inform doctors, researchers and other health professionals by publishing a wide range of peer-reviewed articles.It is distributed free to all medical doctors and allied health professionals in various institutions locally and internationally.Each author must contribute a significant segment and should take responsibility for the content and authenticity of the work as a whole.We also publish editorials and letters intended to inform and spark debate about key medical issues.We do this to complement OMSB’s mission to provide quality healthcare through quality medical education.On behalf of the entire OMJ team, thank you for visiting the online home of the OMJ.We hope you will find this site to be a helpful resource.
Oman Medical Journal is published six times a year by Oman Medical Specialty Board.
Other effective medications include non-sulfonylurea secretagogues, thiazolidinediones, alpha glucosidase inhibitors, and insulin.
Recent research into the pathophysiology of type 2 DM has led to the introduction of new medications like glucagon-like peptide 1 analogoues: dipeptidyl peptidase-IV inhibitors, inhibitors of the sodium-glucose cotransporter 2 and 11ß-hydroxysteroid dehydrogenase 1, insulin-releasing glucokinase activators and pancreatic-G-protein-coupled fatty-acid-receptor agonists, glucagon-receptor antagonists, metabolic inhibitors of hepatic glucose output and quick-release bromocriptine.
In the absence of such committee, the Declaration of Helsinki guidelines must be followed and be clearly stated.
All studies on human subjects must include a statement that the subjects gave informed consent. Photographs need to be cropped to prevent human subjects being recognized.